Cyclic ADP Ribose Hydrolase (CD38) Inhibitors

Benjamin E. Blass

Open source

DOI
10.1021/acsmedchemlett.1c00647
Published
2021-12-25
Container
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsmedchemlett.1c00647,
  title = {Cyclic ADP Ribose Hydrolase (CD38) Inhibitors},
  author = {Benjamin E. Blass},
  year = {2021},
  journal = {ACS Medicinal Chemistry Letters},
  doi = {10.1021/acsmedchemlett.1c00647},
  url = {https://doi.org/10.1021/acsmedchemlett.1c00647}
}

RIS

TY  - JOUR
TI  - Cyclic ADP Ribose Hydrolase (CD38) Inhibitors
AU  - Benjamin E. Blass
PY  - 2021
JO  - ACS Medicinal Chemistry Letters
DO  - 10.1021/acsmedchemlett.1c00647
UR  - https://doi.org/10.1021/acsmedchemlett.1c00647
ER  - 

APA

Blass, B. E. (2021). Cyclic ADP Ribose Hydrolase (CD38) Inhibitors. ACS Medicinal Chemistry Letters. https://doi.org/10.1021/acsmedchemlett.1c00647

Source records